Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Max International is a global health and wellness company primarily focused on the development and distribution of glutathione-enhancing products. The company's flagship product, Cellgevity, utilizes the proprietary RiboCeine technology, which combines D-ribose and L-cysteine to effectively deliver the essential components for glutathione production within cells. Max International operates as a multi-level marketing (MLM) organization, providing nutritional supplements aimed at reducing oxidative stress and supporting cellular health. Their product line is designed to address various aspects of wellness, including energy, weight management, and anti-aging, through the optimization of the body's natural antioxidant defenses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellgevity.